hub and spoke
play

Hub and Spoke Gareth Jones Hub and Spoke What is in the DH Hub - PowerPoint PPT Presentation

Hub and Spoke Gareth Jones Hub and Spoke What is in the DH Hub and Spoke proposal? NPA Hub and Spoke T&F Group DH proposal Amend s10(1) of the Medicines Act 1968 Enable inter-company Hub and Spoke arrangements


  1. Hub and Spoke Gareth Jones

  2. Hub and Spoke • What is in the DH Hub and Spoke proposal? • NPA Hub and Spoke T&F Group

  3. DH proposal • Amend s10(1) of the Medicines Act 1968 • Enable inter-company Hub and Spoke arrangements • “create a level playing field”

  4. DH proposal • Part of the DH narrative on efficiencies – referred to repeatedly at recent Parliamentary meeting by the Minister and Chief Pharmaceutical Officer

  5. DH proposal – “impact assessment” • 45% of medicines will be dispensed in hub and spoke arrangements within 3 years • 10% reduction in pharmacist labour costs in spokes

  6. DH proposal – “impact assessment” • For every job lost in the spoke, 0.4WTE will be created in the hub

  7. DH proposal – “impact assessment” • Capital investment costs excluded from the calculations

  8. NPA Hub and Spoke T&F Group • Manchester University literature review • Over 400 members responded to survey • Visit to an automated hub • Interview 20 experts • Legal opinion from a QC • Members of group from NPA, PSNC and PV

  9. Benefits • Capacity – Some opportunity to support capacity release to deliver other services – No evidence that there are cash savings within pharmacies

  10. More efficient? • Can not reduce staffing in a typical independent – you can redeploy capacity • Reducing staff can be counterproductive and potentially less safe • Hub service fee • Replication of process – Accuracy check in spoke – FMD check in spoke

  11. More efficient? • Ineligible lines • Barriers – Lack of original pack dispensing – Low level of repeat dispensing • Reduce stock levels? • Resilience? • Can MDS packs be done within inter- company Hub and Spoke?

  12. Safer? • Misleading to portray this as a case of humans versus machines • Existing error rate is low • FMD authentication process may deliver the safety benefit without automated dispensing • New opportunities for error

  13. Impact on competition & procurement • Risk of a duopoly due to barriers to entry – DTP / restricted wholesaler schemes – Investment – Infrastructure • Risk to short-liners – Reducing amount of business open to short- liners, challenge to reach critical mass • Risk to the tax-payer

  14. Barriers • EU Falsified Medicines Directive • Accuracy check requirement • DTP/limited wholesaler schemes • Lack of competition between hubs

  15. Enablers • Original pack dispensing • Electronic Repeat Dispensing • New service commitment, eg, Pharmacy First • Public specification for hubs

  16. Enablers • Fair contractual arrangements • GPhC recognition of the additional risks involved within inter-company hub and spoke

  17. Conclusion • The inter-company hub and spoke idea is integral to the Ridge/Cavendish view of the world • DH document shows a complete lack of understanding of the issues • This politically driven proposal, as currently framed, can not deliver the promised level playing field

  18. Conclusion • DH needs to go back to the drawing board • Please respond to the consultation, which closes on 17 th May 2016

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend